Atlas Trials

Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma

Clinical trial NCT07105852 · RECRUITING

Trial details

NCT number
NCT07105852
Sponsor
Sir Run Run Shaw Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cholangiocarcinoma
Start date
2025-07-03
Primary completion
2027-07-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.